LW479, a novel HDAC inhibitor, could be a candidate agent for breast cancer prevention.
References
[1] Li J, et al. Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression. Br J Pharmacol. 2015 Aug;172(15):3817-30. DOI:10.1111/bph.13165
